Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Neutral

Debt to Equity Rating

Sell

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Brainsway Ltd. American Depositary Shares (BWAY)

https://www.brainsway.com

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/17/2019

Market Cap

133,257,612

Shares Outstanding

33,240,000

Weighted SO

16,621,095

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

MDGS --.--%

DCTH --.--%

DCTH --.--%

HSKA --.--%

FNA --.--%

USAQ --.--%

VAPO --.--%

VERO --.--%

TCMD --.--%

Beta

0.3250

Last Div

0.0000

Range

3.02-8.28

Chg

0.1900

Avg Vol

69311

Mkt Cap

133257612

Exch

NASDAQ

Country

IL

Phone

972 2 582 4030

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

3.6578

EV Multiple

44.3897

P/FV

3.0980

Div Yield %

0.0000

P/E

218.9978

PEG

22.7352

Payout

0.0000

Current Ratio

4.7004

Quick Ratio

4.3917

Cash Ratio

3.9461

DSO

38.7533

DIO

149.8283

Op Cycle

188.5815

DPO

64.0302

CCC

124.5513

Gross Margin

0.7482

Op Margin

0.0200

Pretax Margin

0.0214

Net Margin

0.0167

Eff Tax Rate

0.2185

ROA

0.0093

ROE

0.0145

ROCE

0.0137

NI/EBT

0.7815

EBT/EBIT

1.0658

EBIT/Rev

0.0200

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

1.0626

CF/Debt

0.0000

Equity Multi

1.5270

Rec Turnover

9.4186

Pay Turnover

5.7004

Inv Turnover

2.4361

FA Turnover

5.8364

Asset Turnover

0.5551

OCF/Share

0.5014

FCF/Share

0.3486

Cash/Share

2.8884

OCF/Sales

0.2294

FCF/OCF

0.6952

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

3.2807

Div&CapEx Cov

3.2807

P/BV

3.0980

P/B

3.0980

P/S

3.6578

P/E

218.9978

P/FCF

22.9399

P/OCF

15.9347

P/CF

15.9347

PEG

22.7352

P/S

3.6578

EV Multiple

44.3897

P/FV

3.0980

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 10, 07:30 BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology GlobeNewswire Inc. Dec 19, 07:30 BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network GlobeNewswire Inc. Nov 20, 07:30 Louisiana Insurer Expands Deep TMS™ Access for 1.9 Million Covered Lives Benzinga Nov 16, 15:00 5 Analysts Have This to Say About BrainsWay GlobeNewswire Inc. Nov 15, 07:30 BrainsWay Reports Third Quarter 2023 Financial Results and Operational Highlights

Revenue Product Segmentation